68 related articles for article (PubMed ID: 344302)
1. The hyperkinetic child syndrome and brain monoamines: pharmacology and therapeutic implications.
Margolin DI
J Clin Psychiatry; 1978 Feb; 39(2):120-3, 7-30. PubMed ID: 344302
[TBL] [Abstract][Full Text] [Related]
2. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
Solanto MV
Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684
[No Abstract] [Full Text] [Related]
3. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine.
Gross MD
Pediatrics; 1976 Sep; 58(3):423-31. PubMed ID: 958770
[TBL] [Abstract][Full Text] [Related]
4. Actions of dopaminergic agonists on motor function.
Costall B; Naylor RJ
Adv Neurol; 1975; 9():285-97. PubMed ID: 1170715
[No Abstract] [Full Text] [Related]
5. Methylphenidate-induced chorea: case report and pharmacologic implications.
Weiner WJ; Nausieda PA; Klawans HL
Neurology; 1978 Oct; 28(10):1041-4. PubMed ID: 570658
[TBL] [Abstract][Full Text] [Related]
6. Urinary MHPG excretion in the hyperactive child syndrome and the effects of dextroamphetamine [proceedings].
Shekim WO; Dekirmenjian H; Chapel JL
Psychopharmacol Bull; 1978 Apr; 14(2):42-4. PubMed ID: 652929
[No Abstract] [Full Text] [Related]
7. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
Prince J
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
[TBL] [Abstract][Full Text] [Related]
8. Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
Langlais PJ; Gabay S
J Neurosci Res; 1977; 3(2):135-41. PubMed ID: 563925
[TBL] [Abstract][Full Text] [Related]
9. The effect of methylphenidate on cardiovascular sensory differentiation on the hyperkinetic syndrome.
Butter HJ; Lapierre YD
Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):309-14. PubMed ID: 1099022
[TBL] [Abstract][Full Text] [Related]
10. Dopamine and psychotic states: preliminary remarks.
Angrist B; Gershon S
Adv Biochem Psychopharmacol; 1974; 12(0):211-9. PubMed ID: 4371253
[No Abstract] [Full Text] [Related]
11. A neuropharmacological analysis of central nervous system catecholamine systems in development protein malnutrition.
Leahy JP; Stern WC; Resnick O; Morgane PJ
Dev Psychobiol; 1978 Jul; 11(4):361-70. PubMed ID: 566687
[TBL] [Abstract][Full Text] [Related]
12. Dietary cadmium exposure attenuates D-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity.
Miller DK; Dopheide MM; Smith SM; Casteel SW
Pharmacol Biochem Behav; 2005 Apr; 80(4):557-66. PubMed ID: 15820525
[TBL] [Abstract][Full Text] [Related]
13. Studies on dopamine kinetics in rat brain tissue under the influence of morphine.
Kuschinsky K; Celsen B; Huppertz A
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):129-33. PubMed ID: 1172489
[TBL] [Abstract][Full Text] [Related]
14. Blockade by reserpine of methylphenidate-induced release of brain dopamine.
Chiueh CC; Moore KE
J Pharmacol Exp Ther; 1975 May; 193(2):559-63. PubMed ID: 1142104
[TBL] [Abstract][Full Text] [Related]
15. Genetic differences in brain dopamine receptors and amphetamine response: possible model for hyperkinetic children.
Helmeste DM; Seeman P
Prog Clin Biol Res; 1983; 135():401-3. PubMed ID: 6665015
[No Abstract] [Full Text] [Related]
16. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
Izzo E; Sanna PP; Koob GF
Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
[TBL] [Abstract][Full Text] [Related]
17. [Receptor-blockade and receptor-hypersensitivity following neuroleptic treatment (author's transl)].
Nielsen IM; Christensen AV; Hyttel J
Arzneimittelforschung; 1976; 26(6):1090-2. PubMed ID: 989383
[TBL] [Abstract][Full Text] [Related]
18. Growth disturbances in hyperkinetic children.
Greenhill LL; Puig-Antich J; Halpern F; Sachar EJ; Rubinstein B; Chambers W; Fiscina B; Florea J
Pediatrics; 1980 Jul; 66(1):152-4. PubMed ID: 7402783
[No Abstract] [Full Text] [Related]
19. Hyperkinetic syndrome and Tourette syndrome.
Rapoport JL; Nee L; Mitchell S; Polinsky R; Ebert M
Adv Neurol; 1982; 35():423-6. PubMed ID: 6959519
[No Abstract] [Full Text] [Related]
20. Different adaptations in ventral tegmental area dopamine neurons in control and ethanol exposed rats after methylphenidate treatment.
Shen RY; Choong KC
Biol Psychiatry; 2006 Apr; 59(7):635-42. PubMed ID: 16199009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
